US5571500A
(en)
*
|
1987-06-24 |
1996-11-05 |
Autoimmune, Inc. |
Treatment of autoimmune diseases through administration by inhalation of autoantigens
|
US5645820A
(en)
*
|
1987-06-24 |
1997-07-08 |
Autoimmune, Inc. |
Treatment of autoimmune diseases by aerosol administration of autoantigens
|
US5571499A
(en)
*
|
1987-06-24 |
1996-11-05 |
Autoimmune, Inc. |
Treatment of autoimmune diseases by aerosol administration of autoantigens
|
US5869054A
(en)
*
|
1987-06-24 |
1999-02-09 |
Autoimmune Inc. |
Treatment of multiple sclerosis by oral administration of autoantigens
|
US5641474A
(en)
*
|
1987-06-24 |
1997-06-24 |
Autoimmune, Inc. |
Prevention of autoimmune diseases by aerosol administration of autoantigens
|
US6113903A
(en)
*
|
1989-03-21 |
2000-09-05 |
The Immune Response Corporation |
Peptides and methods against diabetes
|
IL99699A
(en)
|
1990-10-10 |
2002-04-21 |
Autoimmune Inc |
Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes
|
US6024090A
(en)
*
|
1993-01-29 |
2000-02-15 |
Aradigm Corporation |
Method of treating a diabetic patient by aerosolized administration of insulin lispro
|
US7448375B2
(en)
*
|
1993-01-29 |
2008-11-11 |
Aradigm Corporation |
Method of treating diabetes mellitus in a patient
|
US5891435A
(en)
*
|
1993-04-16 |
1999-04-06 |
Research Corporation Technologies, Inc. |
Methods and compositions for delaying or preventing the onset of autoimmune disease
|
IS1796B
(is)
*
|
1993-06-24 |
2001-12-31 |
Ab Astra |
Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
|
TW402506B
(en)
|
1993-06-24 |
2000-08-21 |
Astra Ab |
Therapeutic preparation for inhalation
|
US5830853A
(en)
|
1994-06-23 |
1998-11-03 |
Astra Aktiebolag |
Systemic administration of a therapeutic preparation
|
US6632456B1
(en)
|
1993-06-24 |
2003-10-14 |
Astrazeneca Ab |
Compositions for inhalation
|
US6794357B1
(en)
|
1993-06-24 |
2004-09-21 |
Astrazeneca Ab |
Compositions for inhalation
|
US20010003739A1
(en)
*
|
1993-06-24 |
2001-06-14 |
Astrazeneca Ab |
Systemic administration of a therapeutic preparation
|
GB9319429D0
(en)
*
|
1993-09-21 |
1993-11-03 |
London Health Ass |
Methods and products for controlling immune responses in mammals
|
US6165976A
(en)
|
1994-06-23 |
2000-12-26 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
ATE236617T1
(de)
|
1994-12-22 |
2003-04-15 |
Astrazeneca Ab |
Aerosol-arzneiformulierungen
|
SK76797A3
(en)
|
1994-12-22 |
1998-02-04 |
Astra Ab |
Therapeutic preparation for inhalation containing parathyroid hormone, pth
|
US6524557B1
(en)
|
1994-12-22 |
2003-02-25 |
Astrazeneca Ab |
Aerosol formulations of peptides and proteins
|
US6428771B1
(en)
*
|
1995-05-15 |
2002-08-06 |
Pharmaceutical Discovery Corporation |
Method for drug delivery to the pulmonary system
|
US6274549B1
(en)
|
1995-06-30 |
2001-08-14 |
Novo Nordisk A/S |
Treatment of type 1 diabetes
|
US6488933B2
(en)
|
1995-07-05 |
2002-12-03 |
Yeda Research And Development Co. Ltd. |
Preparations for the treatment of T cell mediated diseases
|
US5856446A
(en)
*
|
1995-07-07 |
1999-01-05 |
Autoimmune Inc. |
Method of treating rheumatoid arthritis with low dose type II collagen
|
WO1997009061A1
(en)
*
|
1995-09-06 |
1997-03-13 |
Alexion Pharmaceuticals, Inc. |
Treatment of diabetes via administration of hormonally ineffective insulin
|
SE520392C2
(sv)
*
|
1996-09-27 |
2003-07-01 |
Creative Peptides Sweden Ab C |
Specifika peptider för behandling av diabetes mellitus
|
US20050025758A1
(en)
*
|
1996-10-01 |
2005-02-03 |
Harrison Leonard Charles |
Method and compositions for treatment of insulin-dependant diabetes mellitus
|
EP0914163B1
(en)
*
|
1997-02-28 |
2016-02-24 |
Enzo Therapeutics, Inc. |
Processes implementing selective immune down regulation (SIDR)
|
US5948407A
(en)
*
|
1997-03-19 |
1999-09-07 |
Shire Laboratories Inc. |
Oral induction of tolerance to parenterally administered non-autologous polypeptides
|
DE19733651A1
(de)
*
|
1997-08-04 |
1999-02-18 |
Boehringer Ingelheim Pharma |
Wässrige Aerosolzubereitungen enthaltend biologisch aktive Markomoleküle und Verfahren zur Erzeugung entsprechender Aerosole
|
US20060239930A1
(en)
*
|
1997-08-04 |
2006-10-26 |
Herbert Lamche |
Process for nebulizing aqueous compositions containing highly concentrated insulin
|
US6068844A
(en)
*
|
1997-12-19 |
2000-05-30 |
The United States Of America As Represented By The Department Of Health And Human Services |
Increased resistance to stroke by developing immunologic tolerance to myelin or components thereof
|
US5945123A
(en)
*
|
1998-04-02 |
1999-08-31 |
K-V Pharmaceutical Company |
Maximizing effectiveness of substances used to improve health and well being
|
US20040062802A1
(en)
*
|
1998-04-02 |
2004-04-01 |
Hermelin Victor M. |
Maximizing effectiveness of substances used to improve health and well being
|
US20050197283A1
(en)
*
|
1998-10-04 |
2005-09-08 |
Vascular Biogenics Ltd. |
Compositions containing beta 2-glycoprotein I for the prevention and/or treatment of vascular disease
|
IL126447A
(en)
*
|
1998-10-04 |
2004-09-27 |
Vascular Biogenics Ltd |
An immune preparation that confers tolerance in oral administration and its use in the prevention and / or treatment of atherosclerosis
|
US20060171899A1
(en)
*
|
1998-12-10 |
2006-08-03 |
Akwete Adjei |
Water-stabilized aerosol formulation system and method of making
|
US6417208B1
(en)
*
|
1999-02-05 |
2002-07-09 |
Albert Einstein College Of Medicine Of Yeshiva University |
Method of identification of inhibitors of PDE1C
|
US7534605B2
(en)
|
1999-06-08 |
2009-05-19 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
|
CA2274414A1
(en)
*
|
1999-06-11 |
2000-12-11 |
Universite Laval |
Dietary fish protein for use in restoring normal insulin function insulin-resistant individuals
|
DK2280021T3
(en)
*
|
1999-06-29 |
2016-05-02 |
Mannkind Corp |
Pharmaceutical formulations comprising insulin complexed to a diketopiperazine
|
US9006175B2
(en)
*
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
US6540982B1
(en)
*
|
2000-01-25 |
2003-04-01 |
Aeropharm Technology Incorporated |
Medical aerosol formulation
|
US20100303769A1
(en)
*
|
2000-04-06 |
2010-12-02 |
Franco Wayne P |
Combination growth factor therapy and cell therapy for treatment of acute and chronic heart disease
|
US7166280B2
(en)
*
|
2000-04-06 |
2007-01-23 |
Franco Wayne P |
Combination growth factor therapy and cell therapy for treatment of acute and chronic heart disease
|
US6543682B1
(en)
|
2000-05-03 |
2003-04-08 |
Nichole Glaser |
Insulin-dose calculator disk
|
DE60129550T2
(de)
*
|
2000-05-12 |
2008-04-10 |
The Government Of The United States Of America, As Represented By The Department |
Verwendung von niedrigen dosen estrogen in kombination mit immunotherapeutischen verbindungen zur behandlung von immunkrankheiten
|
US7462486B2
(en)
*
|
2000-05-12 |
2008-12-09 |
Oregon Health & Science University |
Methods of selecting T cell receptor V peptides for therapeutic use
|
WO2001089557A2
(en)
|
2000-05-24 |
2001-11-29 |
The United States Of America, As Represented By Secretary Of The Department Of Health & Human Services |
Methods for preventing strokes by inducing tolerance to e-selectin
|
US6867183B2
(en)
*
|
2001-02-15 |
2005-03-15 |
Nobex Corporation |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
US7060675B2
(en)
*
|
2001-02-15 |
2006-06-13 |
Nobex Corporation |
Methods of treating diabetes mellitus
|
CA2445944A1
(en)
*
|
2001-05-04 |
2002-11-14 |
Pfizer Products Inc. |
Method of preventing type 2 diabetes with aerosolized insulin
|
US6858580B2
(en)
*
|
2001-06-04 |
2005-02-22 |
Nobex Corporation |
Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US7713932B2
(en)
*
|
2001-06-04 |
2010-05-11 |
Biocon Limited |
Calcitonin drug-oligomer conjugates, and uses thereof
|
US6828305B2
(en)
*
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6835802B2
(en)
*
|
2001-06-04 |
2004-12-28 |
Nobex Corporation |
Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
|
US6828297B2
(en)
*
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6713452B2
(en)
*
|
2001-06-04 |
2004-03-30 |
Nobex Corporation |
Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US7196059B2
(en)
*
|
2001-09-07 |
2007-03-27 |
Biocon Limited |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
US20030198666A1
(en)
*
|
2002-01-07 |
2003-10-23 |
Richat Abbas |
Oral insulin therapy
|
ES2300568T3
(es)
|
2002-03-20 |
2008-06-16 |
Mannkind Corporation |
Aparato de inhalacion.
|
CA2524134C
(en)
*
|
2003-04-28 |
2017-07-04 |
Sankyo Company Limited |
Adiponectin production enhancer
|
AU2004233691B2
(en)
*
|
2003-04-28 |
2007-09-20 |
Sankyo Company, Limited |
Sugar intake-ability enhancer
|
US7338171B2
(en)
*
|
2003-10-27 |
2008-03-04 |
Jen-Chuen Hsieh |
Method and apparatus for visual drive control
|
NZ548980A
(en)
*
|
2004-01-12 |
2009-10-30 |
Mannkind Corp |
Reducing serum proinsulin levels in type 2 diabetics
|
DK1740154T3
(da)
|
2004-03-12 |
2009-08-31 |
Biodel Inc |
Insulinsammensætninger med forbedret absorption
|
US20080096800A1
(en)
*
|
2004-03-12 |
2008-04-24 |
Biodel, Inc. |
Rapid mucosal gel or film insulin compositions
|
US20080085298A1
(en)
*
|
2004-03-12 |
2008-04-10 |
Biodel, Inc. |
Rapid Mucosal Gel or Film Insulin Compositions
|
US20080090753A1
(en)
*
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
CA2570916C
(en)
|
2004-06-16 |
2013-06-11 |
Tap Pharmaceutical Products, Inc. |
Pulsed release dosage form of a ppi
|
KR101309770B1
(ko)
|
2004-07-19 |
2013-09-30 |
바이오콘 리미티드 |
인슐린―올리고머 접합체,제형 및 이들의 용도
|
EP1786465A4
(en)
*
|
2004-07-30 |
2009-01-21 |
Univ Oregon Health & Science |
METHODS FOR DETECTION AND TREATMENT OF AUTOIMMUNE DISORDERS
|
WO2006023849A2
(en)
|
2004-08-20 |
2006-03-02 |
Mannkind Corporation |
Catalysis of diketopiperazine synthesis
|
AU2005277041B2
(en)
|
2004-08-23 |
2012-03-22 |
Mannkind Corporation |
Diketopiperazine salts, diketomorpholine salts or diketodioxane salts for drug delivery
|
EP1874334A4
(en)
*
|
2005-04-15 |
2011-03-30 |
Vascular Biogenics Ltd |
COMPOSITIONS WITH BETA 2-GLYCOPROTEIN I-PEPTIDES FOR THE PREVENTION AND / OR TREATMENT OF VASCULAR DISEASES
|
KR20120060245A
(ko)
|
2005-09-14 |
2012-06-11 |
맨카인드 코포레이션 |
활성제에 대한 결정질 미립자 표면의 친화력의 증가를 기반으로 하는 약물 제제화의 방법
|
US7332604B2
(en)
|
2005-09-20 |
2008-02-19 |
Schering Corporation |
1-[[1-[(2-Amino-6-methyl-4-pyridinyl)methyl]-4-fluoro-4-piperidinyl]carbonyl]-4-[2-(2-pyridinyl)-3H-imidazo[4,5-b]pyridin-3-yl]piperidine
|
US20070086952A1
(en)
*
|
2005-09-29 |
2007-04-19 |
Biodel, Inc. |
Rapid Acting and Prolonged Acting Inhalable Insulin Preparations
|
US7713929B2
(en)
|
2006-04-12 |
2010-05-11 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US8084420B2
(en)
*
|
2005-09-29 |
2011-12-27 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
CN104383546B
(zh)
|
2006-02-22 |
2021-03-02 |
曼金德公司 |
用于改善包含二酮哌嗪和活性剂的微粒的药物性质的方法
|
JP2009533471A
(ja)
*
|
2006-04-12 |
2009-09-17 |
バイオデル, インコーポレイテッド |
即効型および長時間作用型組合せインスリン製剤
|
US8217025B2
(en)
*
|
2006-11-17 |
2012-07-10 |
Harbor Therapeutics, Inc. |
Drug screening and treatment methods
|
ES2579229T3
(es)
|
2007-03-13 |
2016-08-08 |
Jds Therapeutics, Llc |
Procedimientos y composiciones para la liberación sostenida de cromo
|
WO2008124522A2
(en)
*
|
2007-04-04 |
2008-10-16 |
Biodel, Inc. |
Amylin formulations
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
AU2008261102B2
(en)
|
2007-06-04 |
2013-11-28 |
Bausch Health Ireland Limited |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
WO2009002867A2
(en)
|
2007-06-26 |
2008-12-31 |
Nutrition 21, Inc. |
Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
|
SG185296A1
(en)
|
2007-10-12 |
2012-11-29 |
Takeda Pharmaceuticals Usa Inc |
Methods of treating gastrointestinal disorders independent of the intake of food
|
CA2702892C
(en)
|
2007-10-16 |
2017-02-28 |
Biocon Limited |
An orally administerable solid pharmaceutical composition and a process thereof
|
WO2009055331A2
(en)
|
2007-10-22 |
2009-04-30 |
Schering Corporation |
Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119
|
EP2077132A1
(en)
|
2008-01-02 |
2009-07-08 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Dispensing device, storage device and method for dispensing a formulation
|
US20090175840A1
(en)
*
|
2008-01-04 |
2009-07-09 |
Biodel, Inc. |
Insulin formulations for insulin release as a function of tissue glucose levels
|
WO2009143049A1
(en)
|
2008-05-19 |
2009-11-26 |
Schering Corporation |
Bicyclic heterocycle derivatives and use thereof as gpr119 modulators
|
ES2522968T3
(es)
|
2008-06-04 |
2014-11-19 |
Synergy Pharmaceuticals Inc. |
Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
|
CN103252007B
(zh)
|
2008-06-13 |
2016-06-22 |
曼金德公司 |
干粉吸入器和用于药物输送的系统
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
US9364619B2
(en)
|
2008-06-20 |
2016-06-14 |
Mannkind Corporation |
Interactive apparatus and method for real-time profiling of inhalation efforts
|
CA2730593A1
(en)
|
2008-07-16 |
2010-01-21 |
Schering Corporation |
Bicyclic heterocycle derivatives and use thereof as gpr119 modulators
|
CA2730603C
(en)
|
2008-07-16 |
2019-09-24 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
EP2318388A2
(en)
|
2008-07-23 |
2011-05-11 |
Schering Corporation |
Tricyclic spirocycle derivatives and methods of use thereof
|
TWI494123B
(zh)
|
2008-08-11 |
2015-08-01 |
Mannkind Corp |
超快起作用胰島素之用途
|
AU2009298617A1
(en)
|
2008-10-03 |
2010-04-08 |
Schering Corporation |
Spiro-imidazolone derivatives as glucagon receptor antagonists
|
CA2739491A1
(en)
|
2008-10-16 |
2010-04-22 |
Schering Corporation |
Azine derivatives and methods of use thereof
|
WO2010075068A1
(en)
|
2008-12-16 |
2010-07-01 |
Schering Corporation |
Pyridopyrimidine derivatives and methods of use thereof
|
US20110243940A1
(en)
|
2008-12-16 |
2011-10-06 |
Schering Corporation |
Bicyclic pyranone derivatives and methods of use thereof
|
WO2010071822A1
(en)
|
2008-12-19 |
2010-06-24 |
Schering Corporation |
Piperidine and piperazine derivatives and methods of use thereof
|
WO2010071819A1
(en)
|
2008-12-19 |
2010-06-24 |
Schering Corporation |
Bicyclic heterocyclic derivatives and methods of use thereof
|
EP2382204B1
(en)
|
2008-12-23 |
2018-07-11 |
Merck Sharp & Dohme Corp. |
Pyrimidine derivatives as gpcr modulators for use in the treatment of obesity and diabetes
|
WO2010075271A1
(en)
|
2008-12-23 |
2010-07-01 |
Schering Corporation |
Bicyclic heterocycle derivatives and methods of use thereof
|
WO2010075273A1
(en)
|
2008-12-23 |
2010-07-01 |
Schering Corporation |
Bicyclic heterocycle derivatives and methods of use thereof
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
KR101635689B1
(ko)
*
|
2009-01-28 |
2016-07-01 |
스마트쎌스, 인크. |
제어 약물 전달을 위한 접합체 기재 시스템
|
US20110293562A1
(en)
|
2009-02-12 |
2011-12-01 |
Proyecto De Biomedicina Cima, S.L. |
Use of cardiotrophin-1 for the treatment of metabolic diseases
|
US9060927B2
(en)
*
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
US8538707B2
(en)
|
2009-03-11 |
2013-09-17 |
Mannkind Corporation |
Apparatus, system and method for measuring resistance of an inhaler
|
US8637507B2
(en)
|
2009-03-18 |
2014-01-28 |
Merck Sharp & Dohme Corp. |
Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
|
WO2010112358A2
(de)
|
2009-03-31 |
2010-10-07 |
Boehringer Ingelheim International Gmbh |
Verfahren zur beschichtung einer oberfläche eines bauteils
|
AR076024A1
(es)
|
2009-04-03 |
2011-05-11 |
Schering Corp |
Derivados de heterociclos biciclicos puenteados y metodos de uso de los mismos
|
US8580807B2
(en)
|
2009-04-03 |
2013-11-12 |
Merck Sharp & Dohme Corp. |
Bicyclic piperidine and piperazine derivatives as GPCR modulators for the treatment of obesity, diabetes and other metabolic disorders
|
EP3508239B1
(de)
|
2009-05-18 |
2020-12-23 |
Boehringer Ingelheim International GmbH |
Adapter, inhalationseinrichtung und zerstäuber
|
WO2010144664A1
(en)
|
2009-06-12 |
2010-12-16 |
Schering Corporation |
Thiophenes as glucagon receptor antagonists, compositions, and methods for their use
|
BRPI1013154B1
(pt)
|
2009-06-12 |
2020-04-07 |
Mannkind Corp |
Micropartículas de dicetopiperazina com áreas de superfície específicas definidas, pó seco compreendendo as referidas micropartículas, método para formação das referidasmicropartículas e formação de micropartículas de fumaril diacetopiperazina, uso das referidas micropartículas e sistema de inalação
|
EP2477498A4
(en)
|
2009-09-14 |
2013-02-27 |
Merck Sharp & Dohme |
DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS
|
EP2485735B1
(en)
|
2009-10-08 |
2015-07-29 |
Merck Sharp & Dohme Corp. |
Inhibitors of fatty acid binding protein (fabp)
|
CA2778684A1
(en)
|
2009-10-29 |
2011-05-05 |
Schering Corporation |
Bridged bicyclic piperidine derivatives and methods of use thereof
|
WO2011056889A1
(en)
|
2009-11-03 |
2011-05-12 |
Mannkind Corporation |
An apparatus and method for simulating inhalation efforts
|
US8912206B2
(en)
|
2009-11-23 |
2014-12-16 |
Merck Sharp & Dohme Corp. |
Pyrimidine ether derivatives and methods of use thereof
|
US20120232073A1
(en)
|
2009-11-23 |
2012-09-13 |
Santhosh Francis Neelamkavil |
Fused bicyclic pyrimidine derivatives and methods of use thereof
|
WO2011066137A1
(en)
|
2009-11-24 |
2011-06-03 |
Schering Corporation |
Substituted biaryl derivatives and methods of use thereof
|
US10016568B2
(en)
|
2009-11-25 |
2018-07-10 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
EP2504051B1
(en)
|
2009-11-25 |
2019-09-04 |
Boehringer Ingelheim International GmbH |
Nebulizer
|
MX2012005961A
(es)
|
2009-11-25 |
2012-06-14 |
Boehringer Ingelheim Int |
Nebulizador.
|
RU2531455C2
(ru)
|
2010-06-21 |
2014-10-20 |
Маннкайнд Корпорейшн |
Системы и способы доставки сухих порошковых лекарств
|
EP2585151B1
(en)
|
2010-06-24 |
2018-04-04 |
Boehringer Ingelheim International GmbH |
Nebulizer
|
JP2013535467A
(ja)
|
2010-07-28 |
2013-09-12 |
スマートセルズ・インコーポレイテツド |
組換えにより発現されたインスリンポリペプチドおよびその使用
|
WO2012027331A1
(en)
|
2010-08-27 |
2012-03-01 |
Ironwood Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
US8603527B2
(en)
*
|
2010-10-25 |
2013-12-10 |
Signal Pharmaceuticals, Llc |
Pharmaceutical formulations of a substituted diaminopurine
|
CN103702672B
(zh)
|
2011-03-01 |
2016-04-27 |
Jds治疗有限公司 |
用于预防和治疗糖尿病、低血糖症及相关病症的胰岛素和铬组合物
|
EP2694220B1
(de)
|
2011-04-01 |
2020-05-06 |
Boehringer Ingelheim International GmbH |
Medizinisches gerät mit behälter
|
SG10201606220QA
(en)
|
2011-04-01 |
2016-09-29 |
Mannkind Corp |
Blister package for pharmaceutical cartridges
|
US9827384B2
(en)
|
2011-05-23 |
2017-11-28 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
CA2852536A1
(en)
|
2011-10-24 |
2013-05-02 |
Mannkind Corporation |
Methods and compositions for treating pain
|
WO2013152894A1
(de)
|
2012-04-13 |
2013-10-17 |
Boehringer Ingelheim International Gmbh |
Zerstäuber mit kodiermitteln
|
BR112015000529B1
(pt)
|
2012-07-12 |
2022-01-11 |
Mannkind Corporation |
Inalador de pó seco
|
US9486433B2
(en)
|
2012-10-12 |
2016-11-08 |
Mochida Pharmaceuticals Co. Ltd. |
Compositions and methods for treating non-alcoholic steatohepatitis
|
EP2911690A1
(en)
|
2012-10-26 |
2015-09-02 |
MannKind Corporation |
Inhalable influenza vaccine compositions and methods
|
US10441560B2
(en)
|
2013-03-15 |
2019-10-15 |
Mochida Pharmaceutical Co., Ltd. |
Compositions and methods for treating non-alcoholic steatohepatitis
|
AU2014235209B2
(en)
|
2013-03-15 |
2018-06-14 |
Bausch Health Ireland Limited |
Guanylate cyclase receptor agonists combined with other drugs
|
WO2014151206A1
(en)
|
2013-03-15 |
2014-09-25 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase and their uses
|
SG11201507288UA
(en)
|
2013-03-15 |
2015-10-29 |
Mochida Pharm Co Ltd |
Compositions and methods for treating non-alcoholic steatohepatitis
|
KR102246914B1
(ko)
|
2013-03-15 |
2021-04-30 |
맨카인드 코포레이션 |
미세결정성 디케토피페라진 조성물 및 방법
|
EP4424697A2
(en)
|
2013-06-05 |
2024-09-04 |
Bausch Health Ireland Limited |
Ultra-pure agonists of guanylate cyclase c, method of making and using same
|
CN114848614A
(zh)
|
2013-07-18 |
2022-08-05 |
曼金德公司 |
热稳定性干粉药物组合物和方法
|
EP3030294B1
(en)
|
2013-08-05 |
2020-10-07 |
MannKind Corporation |
Insufflation apparatus
|
PL2835146T3
(pl)
|
2013-08-09 |
2021-04-06 |
Boehringer Ingelheim International Gmbh |
Nebulizator
|
US9744313B2
(en)
|
2013-08-09 |
2017-08-29 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
CN105792852B
(zh)
|
2013-10-04 |
2019-12-10 |
默沙东公司 |
葡萄糖响应性的胰岛素缀合物
|
WO2015148905A1
(en)
|
2014-03-28 |
2015-10-01 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
ES2941661T3
(es)
|
2014-05-07 |
2023-05-24 |
Boehringer Ingelheim Int |
Nebulizador y recipiente
|
KR102443737B1
(ko)
|
2014-05-07 |
2022-09-19 |
베링거 인겔하임 인터내셔날 게엠베하 |
컨테이너, 분무기 및 사용 방법
|
EP3139984B1
(en)
|
2014-05-07 |
2021-04-28 |
Boehringer Ingelheim International GmbH |
Nebulizer
|
HUE049261T2
(hu)
|
2014-07-15 |
2020-09-28 |
Yissum Research And Development Company Of The Hebrew Univ Of Jerusalem Ltd |
CD44 izolált polipeptidek és alkalmazásaik
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
US9512124B2
(en)
|
2014-10-06 |
2016-12-06 |
Signal Pharmaceuticals, Llc |
Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith
|
CA2902911C
(en)
|
2014-10-31 |
2017-06-27 |
Purdue Pharma |
Methods and compositions particularly for treatment of attention deficit disorder
|
US11865121B2
(en)
|
2016-02-11 |
2024-01-09 |
Nutrition21, LLC |
Chromium containing compositions for improving health and fitness
|
IL262007B2
(en)
|
2016-04-01 |
2023-04-01 |
Signal Pharm Llc |
Modified aminopurine compounds, their compositions and methods of treatment using them
|
RS62496B1
(sr)
|
2016-04-01 |
2021-11-30 |
Signal Pharm Llc |
(1s,4s)-4-(2-(((3s,4r)-3-fluorotetrahidro-2h-piran-4-il)amino)-8-((2,4,6-trihlorofenil)amino)-9h-purin-9-il)-1-metilcikloheksan-1-karboksamid i postupci za njegovu upotrebu
|
JP2020536100A
(ja)
|
2017-10-04 |
2020-12-10 |
セルジーン コーポレイション |
シス−4−[2−{[(3s,4r)−3−フルオロキサン−4−イル]アミノ}−8−(2,4,6−トリクロロアニリノ)−9h−プリン−9−イル]−1−メチルシクロヘキサン−1−カルボキサミドの製造プロセス
|
EA202090884A1
(ru)
|
2017-10-04 |
2020-06-26 |
Селджин Корпорейшн |
Композиции и способы применения цис-4-[2-{[(3s,4r)-3-фтороксан-4-ил]амино}-8-(2,4,6-трихлоранилино)-9н-пурин-9-ил]-1-метилциклогексан-1-карбоксамида
|
US10722473B2
(en)
|
2018-11-19 |
2020-07-28 |
Purdue Pharma L.P. |
Methods and compositions particularly for treatment of attention deficit disorder
|
WO2023200363A1
(ru)
*
|
2022-04-13 |
2023-10-19 |
Фания Иршатовна МАГАНОВА |
Способ получения пероральной формы субстанции, содержащей инсулин
|